Jump to main content
Jump to site search

Issue 12, 2011
Previous Article Next Article

Next-generation sequencing identifies novel microRNAs in peripheral blood of lung cancer patients

Author affiliations

Abstract

MicroRNAs (miRNAs) are increasingly envisaged as biomarkers for various tumor and non-tumor diseases. MiRNA biomarker identification is, as of now, mostly performed in a candidate approach, limiting discovery to annotated miRNAs and ignoring unknown ones with potential diagnostic value. Here, we applied high-throughput SOLiD transcriptome sequencing of miRNAs expressed in human peripheral blood of patients with lung cancer. We developed a bioinformatics pipeline to generate profiles of miRNA markers and to detect novel miRNAs with diagnostic information. Applying our approach, we detected 76 previously unknown miRNAs and 41 novel mature forms of known precursors. In addition, we identified 32 annotated and seven unknown miRNAs that were significantly altered in cancer patients. These results demonstrate that deep sequencing of small RNAs bears high potential to quantify miRNAs in peripheral blood and to identify previously unknown miRNAs serving as biomarker for lung cancer.

Graphical abstract: Next-generation sequencing identifies novel microRNAs in peripheral blood of lung cancer patients

Back to tab navigation

Supplementary files

Publication details

The article was received on 29 Aug 2011, accepted on 10 Oct 2011 and first published on 25 Oct 2011


Article type: Paper
DOI: 10.1039/C1MB05353A
Mol. BioSyst., 2011,7, 3187-3199

  •   Request permissions

    Next-generation sequencing identifies novel microRNAs in peripheral blood of lung cancer patients

    A. Keller, C. Backes, P. Leidinger, N. Kefer, V. Boisguerin, C. Barbacioru, B. Vogel, M. Matzas, H. Huwer, H. A. Katus, C. Stähler, B. Meder and E. Meese, Mol. BioSyst., 2011, 7, 3187
    DOI: 10.1039/C1MB05353A

Search articles by author

Spotlight

Advertisements